We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App





Sysmex Europe Exhibits New Products and Innovative Concepts in Infection Diagnostics at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 11 Apr 2022

Sysmex Europe (Norderstedt, Germany) presented new products and innovative concepts in infection diagnostics at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which took place in Munich, Germany, from 10 to 14 April 2022. More...

In addition to presenting its latest products at the exhibition on a spacious booth, Sysmex Europe underpinned its role as a leading solution and knowledge provider by hosting three educational workshops, plus a variety of further live sessions in a dedicated presentation area.

Sysmex Europe continued supporting the event as a gold sponsor. With a two-storey booth of 128 m2 exhibition space on the ground floor and a further 40 m2 consulting area on the upper floor, Sysmex Europe showcased its competence in the fields of clinical value, workflow automation and digital services, including solutions for new business areas. In line with the brand’s key message of ‘Lighting the way with diagnostics’, Sysmex Europe has the laboratory as well as the clinician and patient in mind and looks at the bigger picture beyond the individual analyser. To strengthen its position further, the company aims at expanding its perception in new business areas while maintaining or increasing the level of trust and loyalty of their existing customers.

Visitors saw a range of new products and innovative concepts on the booth. Besides principal exhibits for the core lab areas such as hematology, haemostasis and urinalysis, and life science solutions for fecal testing, novel highlights were the XQ-320 hematology analyzer, the BloodScience Workcell, the latest clinical flow cytometry solution featuring the XF-1600, and the digital services Caresphere XQC and Sysmex Academy app. Sysmex Europe’s philosophy extends beyond the product itself, and knowing that support and continuous education is of equal importance for a rewarding user experience, the company hosted three 60-minute educational workshops within the congresses’ program, focusing on the clinical value of infection diagnostics from POC to hematology, lean workflow using Sysmex automation concept solutions, and smartening today’s laboratories by means of digital technology and services. To reach a wider audience, these on-site workshops were streamed live via Vimeo on the company’s LinkedIn channel.

Last but not least, an additional range of live lectures and ‘Meet the expert’ sessions including external speakers – in person or virtually – took place in loose succession on the company’s booth in the ‘live presentation area’ using a large, curved screen of approx. 7 x 2.5 m size. All sessions were recorded and are made available on the Sysmex Europe website, while some of these are being additionally shown via the livestream channel.

Related Links:
Sysmex Europe 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
HPV Test
Allplex HPV28 Detection
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.